Back to search
FDAFDA · Food and drugs·Recall number D-0508-2024

Phenylephrine in 0.9% Sodium Chloride Injection Preservative Free, 100mcg/mL, 5mL syringe, Rx only, Hikma Injectables USA Inc, 36 Stults Road, Dayton, NJ 08810, NDC 63037-123-25

Published May 29, 2024 · Recall initiated: April 29, 2024

Summary

FDA records drug Class I recall D-0508-2024, published May 29, 2024 and initiated April 29, 2024. Recalling firm: Hikma Injectables USA Inc; Status: Completed; Lot: Lot #: 240310003D, Exp 6/4/2024. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Label mix-up - ephedrine syringes mislabeled as phenylephrine.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Hikma Injectables USA Inc
Distributor
CO, GA, PA, SD, WA
Lot
Lot #: 240310003D, Exp 6/4/2024
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Phenylephrine in 0.9% Sodium Chloride Injection Preservative Free, 100mcg/mL, 5mL syringe, Rx only, Hikma Injectables USA Inc, 36 Stults Road, Dayton, NJ 08810, NDC 63037-123-25 recalled?

Yes. FDA published recall D-0508-2024 on May 29, 2024. Reported hazard: Labeling: Label mix-up - ephedrine syringes mislabeled as phenylephrine.

What should I do if I have this product?

Voluntary: Firm initiated · Letter